180 related articles for article (PubMed ID: 27365203)
1. Maximising HIV prevention by balancing the opportunities of today with the promises of tomorrow: a modelling study.
Smith JA; Anderson SJ; Harris KL; McGillen JB; Lee E; Garnett GP; Hallett TB
Lancet HIV; 2016 Jul; 3(7):e289-96. PubMed ID: 27365203
[TBL] [Abstract][Full Text] [Related]
2. Epidemiological impact and cost-effectiveness of providing long-acting pre-exposure prophylaxis to injectable contraceptive users for HIV prevention in South Africa: a modelling study.
van Vliet MM; Hendrickson C; Nichols BE; Boucher CA; Peters RP; van de Vijver DA
J Int AIDS Soc; 2019 Dec; 22(12):e25427. PubMed ID: 31855323
[TBL] [Abstract][Full Text] [Related]
3. PrEP for key populations in combination HIV prevention in Nairobi: a mathematical modelling study.
Cremin I; McKinnon L; Kimani J; Cherutich P; Gakii G; Muriuki F; Kripke K; Hecht R; Kiragu M; Smith J; Hinsley W; Gelmon L; Hallett TB
Lancet HIV; 2017 May; 4(5):e214-e222. PubMed ID: 28233660
[TBL] [Abstract][Full Text] [Related]
4. Relative cost-effectiveness of long-acting injectable cabotegravir versus oral pre-exposure prophylaxis in South Africa based on the HPTN 083 and HPTN 084 trials: a modelled economic evaluation and threshold analysis.
Jamieson L; Johnson LF; Nichols BE; Delany-Moretlwe S; Hosseinipour MC; Russell C; Meyer-Rath G
Lancet HIV; 2022 Dec; 9(12):e857-e867. PubMed ID: 36356603
[TBL] [Abstract][Full Text] [Related]
5. Evaluating the potential impact and cost-effectiveness of dapivirine vaginal ring pre-exposure prophylaxis for HIV prevention.
Reidy M; Gardiner E; Pretorius C; Glaubius R; Torjesen K; Kripke K
PLoS One; 2019; 14(6):e0218710. PubMed ID: 31242240
[TBL] [Abstract][Full Text] [Related]
6. Combined interventions to reduce HIV incidence in KwaZulu-Natal: a modelling study.
Blaizot S; Huerga H; Riche B; Ellman T; Shroufi A; Etard JF; Ecochard R
BMC Infect Dis; 2017 Jul; 17(1):522. PubMed ID: 28747167
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of Injectable Preexposure Prophylaxis for HIV Prevention in South Africa.
Glaubius RL; Hood G; Penrose KJ; Parikh UM; Mellors JW; Bendavid E; Abbas UL
Clin Infect Dis; 2016 Aug; 63(4):539-47. PubMed ID: 27193745
[TBL] [Abstract][Full Text] [Related]
8. The new role of antiretrovirals in combination HIV prevention: a mathematical modelling analysis.
Cremin I; Alsallaq R; Dybul M; Piot P; Garnett G; Hallett TB
AIDS; 2013 Jan; 27(3):447-58. PubMed ID: 23296196
[TBL] [Abstract][Full Text] [Related]
9. Portfolios of biomedical HIV interventions in South Africa: a cost-effectiveness analysis.
Long EF; Stavert RR
J Gen Intern Med; 2013 Oct; 28(10):1294-301. PubMed ID: 23588668
[TBL] [Abstract][Full Text] [Related]
10. Future HIV epidemic trajectories in South Africa and projected long-term consequences of reductions in general population HIV testing: a mathematical modelling study.
Rautenbach SP; Whittles LK; Meyer-Rath G; Jamieson L; Chidarikire T; Johnson LF; Imai-Eaton JW
Lancet Public Health; 2024 Apr; 9(4):e218-e230. PubMed ID: 38553141
[TBL] [Abstract][Full Text] [Related]
11. Individual and community-level benefits of PrEP in western Kenya and South Africa: Implications for population prioritization of PrEP provision.
Mudimu E; Peebles K; Mukandavire Z; Nightingale E; Sharma M; Medley GF; Klein DJ; Kripke K; Bershteyn A
PLoS One; 2020; 15(12):e0244761. PubMed ID: 33382803
[TBL] [Abstract][Full Text] [Related]
12. Dapivirine vaginal ring for HIV prevention: modelling health outcomes, drug resistance and cost-effectiveness.
Glaubius R; Ding Y; Penrose KJ; Hood G; Engquist E; Mellors JW; Parikh UM; Abbas UL
J Int AIDS Soc; 2019 May; 22(5):e25282. PubMed ID: 31074936
[TBL] [Abstract][Full Text] [Related]
13. The potential impact and cost of focusing HIV prevention on young women and men: A modeling analysis in western Kenya.
Alsallaq RA; Buttolph J; Cleland CM; Hallett T; Inwani I; Agot K; Kurth AE
PLoS One; 2017; 12(4):e0175447. PubMed ID: 28403211
[TBL] [Abstract][Full Text] [Related]
14. Applying the HIV Prevention Cascade to an Evaluation of a Large-Scale Combination HIV Prevention Programme for Adolescent Girls and Young Women in South Africa.
Bergh K; Toska E; Duby Z; Govindasamy D; Mathews C; Reddy T; Jonas K
AIDS Behav; 2024 Apr; 28(4):1137-1151. PubMed ID: 37462890
[TBL] [Abstract][Full Text] [Related]
15. Determinants of heterosexual men's demand for long-acting injectable pre-exposure prophylaxis (PrEP) for HIV in urban South Africa.
Cheng CY; Quaife M; Eakle R; Cabrera Escobar MA; Vickerman P; Terris-Prestholt F
BMC Public Health; 2019 Jul; 19(1):996. PubMed ID: 31340785
[TBL] [Abstract][Full Text] [Related]
16. Modelling impact and cost-effectiveness of oral pre-exposure prophylaxis in 13 low-resource countries.
Pretorius C; Schnure M; Dent J; Glaubius R; Mahiane G; Hamilton M; Reidy M; Matse S; Njeuhmeli E; Castor D; Kripke K
J Int AIDS Soc; 2020 Feb; 23(2):e25451. PubMed ID: 32112512
[TBL] [Abstract][Full Text] [Related]
17. Modelling the impact and cost-effectiveness of combination prevention amongst HIV serodiscordant couples in Nigeria.
Mitchell KM; Lépine A; Terris-Prestholt F; Torpey K; Khamofu H; Folayan MO; Musa J; Anenih J; Sagay AS; Alhassan E; Idoko J; Vickerman P
AIDS; 2015 Sep; 29(15):2035-44. PubMed ID: 26355574
[TBL] [Abstract][Full Text] [Related]
18. Optimal uses of antiretrovirals for prevention in HIV-1 serodiscordant heterosexual couples in South Africa: a modelling study.
Hallett TB; Baeten JM; Heffron R; Barnabas R; de Bruyn G; Cremin Í; Delany S; Garnett GP; Gray G; Johnson L; McIntyre J; Rees H; Celum C
PLoS Med; 2011 Nov; 8(11):e1001123. PubMed ID: 22110407
[TBL] [Abstract][Full Text] [Related]
19. Comparative effectiveness and cost-effectiveness of antiretroviral therapy and pre-exposure prophylaxis for HIV prevention in South Africa.
Alistar SS; Grant PM; Bendavid E
BMC Med; 2014 Mar; 12():46. PubMed ID: 24629217
[TBL] [Abstract][Full Text] [Related]
20. Can the Heterosexual HIV Epidemic be Eliminated in South Africa Using Combination Prevention? A Modeling Analysis.
Abuelezam NN; McCormick AW; Fussell T; Afriyie AN; Wood R; DeGruttola V; Freedberg KA; Lipsitch M; Seage GR
Am J Epidemiol; 2016 Aug; 184(3):239-48. PubMed ID: 27416841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
